News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Baxter International, Inc. (BAX) Opens $56 Million R&D Center In Suzhou


6/4/2014 2:24:41 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 4, 2014 -- Baxter International officially opened a $56 million China R&D center in Suzhou Industrial Park, the company’s first R&D center in China. The Suzhou facility was charged with the mission of developing Baxter's global R&D network further and, at the same time, providing better medical services for Chinese patients. Baxter makes both biopharmaceuticals (hemophilia and kidney treatments plus vaccines) and medical products. The company plans to split into two entities during 2015, with medical products retaining the Baxter name. More details....

Stock Symbol: (NYSE: BAX)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES